Shouzheng Wang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Chest Hospital, Fu Wai Hospital · ORCID：0000-0003-3697-4643

发表论文 18 篇 · 总被引 105 次 · h-index 6

代表论文

• Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA (2022 · Thoracic Cancer · 被引 40)
• Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study) (2022 · Cancers · 被引 19)
• Patients with non‑small cell lung cancer with the exon 21 L858R mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (Review) (2024 · Oncology Letters · 被引 15)
• Bioresorbable vs Metallic Occluders for Transcatheter Atrial Septal Defect Closure (2025 · JAMA · 被引 9)
• Low TP53 variant allele frequency as a biomarker for anti‐programmed death (ligand) 1 monotherapy in lung adenocarcinoma (2023 · Cancer · 被引 8)
• Evolutionary Characteristics and Immunologic Divergence of Lung and Brain Metastasis Lesions in NSCLC (2022 · Molecular Cancer Research · 被引 8)